Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

ClinicalTrials.gov ID: NCT00300196

Public ClinicalTrials.gov record NCT00300196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 1:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ASP II (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute Ischemic Stroke

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to determine whether a brief intravenous infusion of ancrod started within 6 hours of stroke onset improves functional outcome at 3 months.

Study identification

NCT ID
NCT00300196
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Neurobiological Technologies
Industry
Enrollment
311 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2006 (Type not available)
Primary completion
Dec 2008 (Actual)
Completion
Dec 2008 (Actual)
Last update posted
Jan 12, 2010

2006 – 2008

United States locations

U.S. sites
39
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Enloe Medical Center Chico California 95973 —
UCSF-Fresno Fresno California 93701 —
Sherry Braheny MD - A Prof. Corporation La Mesa California 91942 —
Mercy General Hospital Sacramento California 95825 —
Los Robles Hospital and Medical Center Thousand Oaks California 91360 —
Yale University School of Medicine New Haven Connecticut 06510 —
Manatee Memorial Hospital Bradenton Florida 34208 —
Bradenton Research Center Bradenton Florida 34250 —
Melbourne Internal Medicine Associates Melbourne Florida 32901 —
Collier Neurologic Specialists Naples Florida 34102 —
Naples Community Hospital Naples Florida 34102 —
Suncoast Neuroscience Associates St. Petersburg Florida 33701 —
Joan Glancy Memorial Hospital Decatur Georgia 30033 —
Joan Glancy Memorial Hospital Duluth Georgia 30096 —
Gwinnett Medical Center Lawrenceville Georgia 30045 —
Dekalb Medical Center-Hillandale Lithonia Georgia 30058 —
Candler Hospital Savannah Georgia 31405 —
St. Joseph's Hospital Savannah Georgia 31419 —
OSF Saint Joseph Medical Center Bloomington Illinois 61701 —
Bromenn Regional Medical Center Normal Illinois 61761 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
Saint Luke's Hospital Mid America Brain and Stroke Institute Kansas City Missouri 64111 —
Research Medical Center Kansas City Missouri 64132 —
St. Louis University Hospital - Dept of Neurology St Louis Missouri 63110 —
Nevada Neuroscience Institute at Sunrise Las Vegas Nevada 89109 —
Jersey Shore University Medical Center Neptune City New Jersey 07753 —
Neuroscience Institute St Francis Medical Center Trenton New Jersey 08629 —
Lutheran Medical Center Brooklyn New York 11220 —
Five Towns Neuroscience Research Lawrence New York 11559 —
Aultman Hospital Canton Ohio 44710 —
Charles F. Kettering Memorial Hospital Kettering Ohio 45429 —
Doylestown Hospital Doylestown Pennsylvania 18901 —
Lancaster General Hospital Lancaster Pennsylvania 17603 —
Hahenmann University Hospital Philadelphia Pennsylvania 19102-1101 —
AnMed Health Anderson South Carolina 29621 —
Chattanooga Center for Neurologic Research Chattanooga Tennessee 97401 —
Overlake Hospital Medical Center Bellevue Washington 98004 —
Providence St. Peter Hospital Olympia Washington 98506 —
CAMC Memorial Hospital Charleston West Virginia 25304 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00300196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2010 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00300196 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →